Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
about
Indacaterol, a once-daily beta2-agonist, versus twice-daily beta2-agonists or placebo for chronic obstructive pulmonary diseaseLong-acting inhaled therapy (beta-agonists, anticholinergics and steroids) for COPD: a network meta-analysisTiotropium versus long-acting beta-agonists for stable chronic obstructive pulmonary diseaseHealth-related quality of life measurement in asthma and chronic obstructive pulmonary disease: review of the 2009-2014 literaturePositioning new pharmacotherapies for COPDTen years of tiotropium: clinical impact and patient perspectivesImproving the quality of life in patients with chronic obstructive pulmonary disease: focus on indacaterolA year in review: new drugs for older adults in 2011Postapproval Development Options in COPD: A Case Study in Value-Based Healthcare Systems.Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol.Bronchodilator efficacy and safety of indacaterol 150 μg once daily in patients with COPD: an analysis of pooled dataEfficacy of once-daily indacaterol 75 μg relative to alternative bronchodilators in COPD: a study level and a patient level network meta-analysisCOPD: maximization of bronchodilation.Indacaterol for chronic obstructive pulmonary disease: systematic review and meta-analysisInfluence of indacaterol on daily physical activity in patients with untreated chronic obstructive pulmonary diseaseSafety of indacaterol in the treatment of patients with COPD.Comparison of clinical efficacy and safety between indacaterol and tiotropium in COPD: meta-analysis of randomized controlled trialsEffects of indacaterol versus tiotropium on respiratory mechanics assessed by the forced oscillation technique in patients with chronic obstructive pulmonary disease.A real-world evaluation of indacaterol and other bronchodilators in COPD: the INFLOW study.Effect of indacaterol on lung deflation improves cardiac performance in hyperinflated COPD patients: an interventional, randomized, double-blind clinical trialThe role of bronchodilator treatment in the prevention of exacerbations of COPD.Indacaterol in chronic obstructive pulmonary disease: an update for clinicians.Pharmacotherapies for COPD.Indacaterol: a comprehensive review.Chronic obstructive pulmonary disease in China: the potential role of indacaterolGuidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.A new class of bronchodilator improves lung function in COPD: a trial with GSK961081.Differences in physical activity according to mMRC grade in patients with COPDEffects of indacaterol versus tiotropium on exercise tolerance in patients with moderate COPD: a pilot randomized crossover study.Role of indacaterol, a once-daily bronchodilator, in chronic obstructive pulmonary disease.Efficacy of indacaterol on quality of life and pulmonary function in patients with COPD and inhaler device preferences.Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease.Long-acting β-adrenoceptor agonists in the management of COPD: focus on indacaterol.Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease.Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease.Indacaterol: a new long-acting β2-agonist in the management of chronic obstructive pulmonary disease.Future of chronic obstructive pulmonary disease management.Indacaterol 75 μg once daily for the treatment of patients with chronic obstructive pulmonary disease: a North American perspective.Role of indacaterol and the newer very long-acting β2-agonists in patients with stable COPD: a review
P2860
Q24186652-67C03800-3489-48DD-957C-E90079EBC909Q24197853-66CFD6A7-AADB-4D49-AD27-426598E48C36Q24200476-8F615272-4E09-4905-BF41-0994A6DAAFA9Q26765780-75BEF1C8-056B-4BA0-BFC7-5A31C9E7FCECQ26798659-D3F8BD7E-D4C0-4B1F-A29F-6A56EB287F48Q26823682-0E0957AB-CC84-40BF-8809-CB1538C29014Q26851664-7E451D4E-200D-482B-B10F-C34751ACBBB0Q33637890-83A9381F-F478-41C8-9F5F-94586AB9871EQ33932267-932A4240-0D59-4E1F-A44E-1FFAB1EEA090Q34011640-01557E98-2976-4DB7-AB30-CC81071EA8BDQ34049219-C338C81A-CA3F-44E2-B7B2-4B889272C53DQ34316776-796ED21F-66CE-43A7-9030-899E1536AE56Q34436393-F93EFD29-BB4C-434E-9AD8-19875201B697Q34962838-41B365E7-51EF-4B0F-A86A-D1F43CEC6781Q35161561-C7916CD4-A91B-4A5C-80BF-797556DB6917Q35268351-38DAE607-2809-451B-AC51-19B20200F99BQ35584046-9741442A-5D95-4236-8757-71DD41042518Q35766357-6AD8429F-EE85-4561-8F55-F89382E5006FQ35816973-3CEA7BF6-9D79-4B5C-A2B0-D67038A77A86Q36072399-CA05489B-D1AF-4E85-B30D-138E2C2239B1Q36438669-03762F3C-78F2-40EB-958B-C82E2FE82A88Q36443777-18105A70-18E7-4428-BC29-1F8683C9AE9DQ36843717-F9F54D97-3553-4601-865E-CCCBD10FCAACQ37057061-180B9C62-7A6D-452C-9A5C-706F6ABC9D17Q37128034-5FC8BD7C-BF52-49F8-80AA-000072EB5C13Q37177278-D85F85B3-A506-4E24-AEF2-3B92C8013DD8Q37209304-7F3E6EB3-E206-4DEF-BC7A-3FA278C4B39CQ37265683-2576C8C3-B5A6-48DC-BBE9-93325049B56DQ37392356-DAFE8F34-4635-406C-BB78-8C749DE15C91Q37457359-559A6499-FCCE-45E7-ACD3-07D6CBEEEABFQ37524951-5E752E56-74F8-4E77-9CBB-A10EEBF6F885Q37614103-47081CB6-B93C-4200-B151-83E88158E600Q37615959-5888DD8E-30DF-40B6-A95D-AB1FB921799DQ37911291-EB9B5174-EEED-4462-9EF1-7691ED324927Q37973132-07D1AAD4-7FE1-487E-A53A-C1E2152694D2Q37987211-AEB9226E-5E0F-4251-97E5-CED03889F107Q37999465-3643AC9A-BB3F-44C4-A460-5038EFC2F8FBQ38025725-8D2814A4-1C35-4465-BD6C-58B2E5002A35Q38072277-B572CCF3-BF9A-4C40-A3D6-09FB2DAB6362Q38148145-6D711355-D5F1-4676-9BBC-0F58AD4308DD
P2860
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@ast
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@en
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@nl
type
label
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@ast
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@en
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@nl
prefLabel
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@ast
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@en
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@nl
P2093
P1476
Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD.
@en
P2093
INTENSITY study investigators
P304
P356
10.1183/09031936.00191810
P577
2011-05-26T00:00:00Z